Cargando…
Innovation in Biomedicine: Can Stem Cell Research Lead the Way to Affordability?
In 2004, California voters approved a US$3 billion stem cell research program. Goozner outlines his innovative suggestions for ensuring that any treatments resulting from the program will be made affordable for state residents.
Autor principal: | Goozner, Merrill |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1382006/ https://www.ncbi.nlm.nih.gov/pubmed/16492088 http://dx.doi.org/10.1371/journal.pmed.0030126 |
Ejemplares similares
-
Responsible Oversight of Human Stem Cell Research: The California Institute for Regenerative Medicine's Medical and Ethical Standards
por: Lomax, Geoffrey P, et al.
Publicado: (2007) -
New era of drug innovation in China
por: Ye, Xuan, et al.
Publicado: (2019) -
Syndromic Surveillance: Adapting Innovations to Developing Settings
por: Chretien, Jean-Paul, et al.
Publicado: (2008) -
Evolution of drug regulations and regulatory innovation for anticancer drugs in China
por: Liu, Yang, et al.
Publicado: (2022) -
Malaria in Pregnancy: What Can the Social Sciences Contribute?
por: Ribera, Joan Muela, et al.
Publicado: (2007)